Predicting the course of myasthenic weakness following double filtration plasmapheresis

Acta Neurologica Scandinavica

Volumn 108, Issue 3, 2003, Pages 174-178

  Yeh, J H ^a   Chen, W H ^a   Chiu, Hou Chang ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acetylcholine receptor antibody; Clinical worsening; Double filtration plasmapheresis; Myasthenia gravis; Plasmapheresis; Serological rebound

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; DOUBLE FILTRATION PLASMAPHERESIS; FEMALE; FOLLOW UP; HUMAN; MALE; MYASTHENIA; MYASTHENIA GRAVIS; PLASMAPHERESIS; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FILTRATION; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; PLASMAPHERESIS; PROGNOSIS; RECEPTORS, CHOLINERGIC; TIME FACTORS;

EID: 0041926661     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00107.x     Document Type: Article

References (19)

1. DRACHMAN DB, ADAMS RN, JOSIFEK LF, SELF SG. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982;307:769-75.
2. KUKS JM, DAS PC. Plasma exchange in myasthenia gravis. Int J Artif Organs 1998;21:188-91.
3. OOSTERHUIS HJGH, LIMBURG PC, HUMMEL-TAPPEL R. The TH. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients. J Neurol Sci 1983;58:371-85.
4. YEH JH, CHIU HC. Plasmapheresis in myasthenia gravis - comparative study of daily versus alternately daily schedule. Acta Neurol Scand 1999;99:147-51.
5. GROB D, SIMPSON D, MITSUMOTO H et al. Treatment of myasthenia gravis by imunoadsorption of plasma. Neurology 1995;5:338-44.
6. SHIBUYA N, SATO T, OSAME M, TAKEGAMI T, DOI S, KAWANAMI S. Immunoadsorption therapy for myasthenia gravis. J Neurol Neurosurg Psychiatry 1994;57:578-81.
7. KORNFELD P, AMBINDER EP, MITTAG T et al. Plasmapheresis in refractory generalized myasthenia gravis. Arch Neurol 1981;38:478-81.
8. NEWSOM-DAVIS J, PINCHING AJ, VINCENT A, WILSON SG. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 1978;28:266-72.
9. YEH JH, CHIU HC. Double filtration plasmapheresis in myasthenia gravis-analysis of clinical efficacy and prognostic parameters. Acta Neurol Scand 1999;100:305-9.
10. DAU PC. Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients. Ann NY Acad Sci 1981;377:700-8.
11. MILNER-BROWN HS, MILLER RG. Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravis. J Neurol Sci 1982;57:357-68.
12. YEH JH, CHIU HC. Optimal volume of processed plasma and total number of selective plasmapheresis sessions in the treatment of patients with severe generalized myasthenia gravis. J Clin Apheresis 1999;14:177-80.
13. THORLACIUS S, LEFVERT AK, AARLI JA et al. Plasma exchange in myasthenia gravis: effect on anti-acetylcholine receptor antibodies and other autoantibodies. Acta Neurol Scand 1986;74:486-90.
14. TINDALL RB. Humoral immunity - myasthenia gravis. Biochemical characterization of acquired anti-receptor antibodies and clinical correlation. Ann Neurol 1981;10:437-47.
15. BESINGER KA, TOYKA KV, HEININGER A et al. Long term correlation of clinical course and acetylcholine receptor antibody in patients with myasthenia gravis. Ann NY Acad Sci 1981;377:812-5.
16. KORNFELD P, FOX S, MAIER K, MAHJOUB M. Ten years experience with therapeutic apheresis in a community hospital. J Clin Apheresis 1992;7:63-8.
17. ROSES AS, OLANOW CW, MCADAMS MW, LANE RJM. No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis. Neurology 1981;31:220-4.
18. ANTOZZI C, GEMMA M, REGI B et al. A short plasma exchange protocol is effective in severe myasthenia gravis. J Neurol 1991;238:103-7.
19. CARTER B, HARRISON R, LUNT GG, BEHAN PO, SIMPSON JA. Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy. J Neurol Neurosurg Psychiatry 1980;43:397-402.